Serum GADD45a methylation is a useful biomarker to distinguish benign vs malignant prostate disease. [electronic resource]
Producer: 20151014Description: 460-8 p. digitalISSN:- 1532-1827
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.